LC

Lipi Chatterjee

Active Director Director DIN 09837118
DIN 09837118 First appointment Dec 2022 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Dec 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Lipi Chatterjee

Data last updated:

Lipi Chatterjee is a Director at Rhine Pharma Private Limited (since 2024) and Designated Partner at Riel Pharma Llp (since 2022). The companies operate in Paper and Chemicals.

DIN 09837118
Primary Designation Director
Industry Paper
First Appointment 26 Dec 2022
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rhine Pharma Private Limited U21001WB2024PTC274213
Director23 Oct 20242024Active
Riel Pharma Llp AAW-9985
Designated Partner26 Dec 20222021Active

Board colleagues of Lipi Chatterjee

NameDINCompanyDesignation
Seikh Fayejul Bary11368030Rhine Pharma Private LimitedDirector
Sk Rejaul Bari09172051Riel Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Riel Pharma Llp
Rhine Pharma Private Limited
Premium access

Shareholding and investment profile for Lipi Chatterjee

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lipi Chatterjee

Lipi Chatterjee currently holds 2 directorships: Rhine Pharma Private Limited (Director, since 23 Oct 2024); Riel Pharma Llp (Designated Partner, since 26 Dec 2022).

Lipi Chatterjee was first appointed on 26 Dec 2022 as Designated Partner at Riel Pharma Llp. The most recent appointment on record is 23 Oct 2024 at Rhine Pharma Private Limited.

The current boards of Lipi Chatterjee's companies include Seikh Fayejul Bary (Rhine Pharma Private Limited), Sk Rejaul Bari (Riel Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available